Estados financieros detallados de Niagen Bioscience Inc (NAGE): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Niagen Bioscience Inc registró ingresos de $129.4M en el último ejercicio fiscal, con un CAGR de 5 años del 16.9%.
Márgenes de los últimos 12 meses: margen bruto 64.2%, margen operativo 6.7%, margen neto 12.4%.
Al precio actual de $3.00, NAGE cotiza a un P/E de 15.45 y un ROE del 20.50%. La capitalización bursátil es de $239M.
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Ingresos | $21.7M | $21.2M | $31.6M | $46.3M | $59.3M | $67.4M | $72.0M | $83.6M | $99.6M | $129.4M |
| Coste de Ventas | $11.3M | $10.7M | $15.5M | $20.5M | $24.0M | $26.0M | $29.3M | $32.8M | $38.0M | $46.2M |
| Beneficio Bruto | $10.4M | $10.5M | $16.1M | $25.8M | $35.3M | $41.5M | $42.8M | $50.8M | $61.6M | $83.2M |
| I+D | $2.5M | $4.0M | $5.5M | $4.4M | $3.4M | $3.8M | $4.8M | $5.0M | $6.0M | $6.3M |
| Generales y Administrativos | $10.8M | $22.1M | $43.7M | $52.5M | $51.7M | $64.7M | $56.6M | $51.4M | $47.8M | $62.6M |
| Gastos Operativos | $13.3M | $26.9M | $49.2M | $57.1M | $55.1M | $68.6M | $61.4M | $56.4M | $53.9M | $68.9M |
| Beneficio Operativo | -$2.9M | -$16.4M | -$33.2M | -$31.3M | -$19.9M | -$27.1M | -$18.6M | -$5.6M | $7.7M | $14.3M |
| EBITDA | -$2.5M | -$15.7M | -$32.3M | -$29.8M | -$18.3M | -$25.4M | -$14.7M | -$3.2M | $10.3M | $19.6M |
| Gastos por Intereses | $371899 | $153000 | $79000 | $847000 | $71000 | $55000 | 0 | 0 | 0 | 0 |
| Beneficio Antes de Impuestos | -$3.6M | -$16.5M | -$33.3M | -$32.1M | -$19.9M | -$27.1M | -$16.5M | -$4.9M | $8.9M | $18.2M |
| Impuestos | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $305000 | $810000 |
| Beneficio Neto | -$2.9M | -$11.4M | -$33.3M | -$32.1M | -$19.9M | -$27.1M | -$16.5M | -$4.9M | $8.6M | $17.4M |
| BPA | $-0.08 | $-0.26 | $-0.61 | $-0.56 | $-0.33 | $-0.40 | $-0.24 | $-0.07 | $0.11 | $0.22 |
| BPA Diluido | $-0.08 | $-0.26 | $-0.61 | $-0.56 | $-0.33 | $-0.40 | $-0.24 | $-0.07 | $0.11 | $0.20 |
| Acciones en Circulación (Diluidas) | $37.3M | $44.6M | $55.0M | $57.1M | $61.1M | $67.2M | $69.7M | $75.0M | $79.7M | $85.4M |
Cuenta de Resultados (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Ingresos | $34.0M | $33.8M | $31.5M | $29.8M |
| Beneficio Bruto | $21.9M | $21.7M | $20.0M | $19.3M |
| Beneficio Operativo | $4.2M | $2.1M | $1.6M | $700000 |
| EBITDA | $5.0M | $5.3M | $7.0M | $1.2M |
| Beneficio Neto | $4.6M | $4.1M | $6.3M | $963000 |
| BPA | $0.05 | $0.05 | $0.08 | $0.01 |
| BPA Diluido | $0.05 | $0.05 | $0.07 | $0.01 |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Caja y Equivalentes | $1.6M | $45.4M | $22.4M | $18.6M | $16.5M | $28.0M | $20.3M | $27.2M | $44.5M | $64.8M |
| Inversiones a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cuentas por Cobrar | $5.9M | $5.3M | $4.4M | $2.2M | $2.7M | $5.2M | $8.5M | $5.2M | $7.8M | $9.7M |
| Inventario | $7.9M | $5.8M | $8.2M | $11.5M | $11.7M | $13.6M | $14.7M | $14.5M | $9.2M | $20.4M |
| Activos Corrientes | $15.7M | $57.2M | $36.5M | $33.5M | $32.2M | $48.9M | $46.6M | $49.5M | $64.1M | $96.8M |
| Inmovilizado Material | $1.8M | $2.9M | $3.6M | $4.7M | $4.4M | $7.4M | $6.3M | $4.5M | $3.4M | $3.5M |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | $486000 | $1.7M | $1.5M | $1.3M | $1.1M | $857000 | $671000 | $510000 | $359000 | $5.7M |
| Activos Totales | $19.8M | $62.7M | $42.2M | $40.2M | $38.4M | $57.8M | $54.1M | $55.0M | $68.3M | $106.4M |
| Cuentas por Pagar | $6.0M | $3.7M | $9.5M | $9.6M | $9.4M | $10.4M | $9.7M | $10.2M | $8.5M | $10.8M |
| Deuda a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $1.0M |
| Pasivos Corrientes | $8.9M | $8.1M | $14.4M | $15.1M | $16.5M | $17.6M | $17.9M | $20.6M | $17.9M | $19.9M |
| Deuda a Largo | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Totales | $9.8M | $8.9M | $15.1M | $19.8M | $21.9M | $26.1M | $25.4M | $26.5M | $22.2M | $29.9M |
| Reservas | -$45.2M | -$56.6M | -$89.8M | -$121.9M | -$141.8M | -$169.0M | -$185.5M | -$190.5M | -$181.9M | -$164.5M |
| Patrimonio Neto | $10.0M | $53.8M | $27.2M | $20.4M | $16.4M | $31.7M | $28.7M | $28.5M | $46.1M | $76.5M |
| Deuda Total | $599050 | $506000 | $310000 | $1.7M | $1.6M | $4.7M | $4.3M | $3.3M | $2.7M | $2.8M |
| Deuda Neta | -$1.0M | -$44.9M | -$22.1M | -$16.9M | -$14.9M | -$23.3M | -$16.0M | -$23.9M | -$41.9M | -$62.0M |
| Capital Circulante | $6.9M | $49.1M | $22.1M | $18.5M | $15.7M | $31.3M | $28.7M | $28.9M | $46.2M | $76.9M |
Balance (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Caja y Equivalentes | $64.1M | $64.8M | $66.5M | $66.7M |
| Activos Totales | $98.1M | $106.4M | $114.3M | $106.6M |
| Pasivos Totales | $27.5M | $29.9M | $32.0M | $24.1M |
| Patrimonio Neto | $70.7M | $76.5M | $82.3M | $82.5M |
| Deuda Total | $3.1M | $2.8M | $2.6M | $2.3M |
Flujo de Caja (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Beneficio Neto | -$2.9M | -$11.4M | -$33.3M | -$32.1M | -$19.9M | -$27.1M | -$16.5M | -$4.9M | $8.6M | $17.4M |
| Amortizaciones | $419560 | $716000 | $842000 | $1.5M | $1.5M | $1.6M | $1.9M | $1.7M | $1.5M | $1.4M |
| Compensación en Acciones | $1.2M | $4.6M | $6.4M | $7.2M | $6.9M | $6.2M | $5.7M | $4.8M | $3.7M | $6.1M |
| Cambio en Capital Circulante | -$2.8M | $2.0M | $5.2M | $427000 | $1.1M | -$4.7M | -$6.0M | $4.6M | $3.1M | -$8.3M |
| Flujo de Caja Operativo | -$2.9M | -$9.8M | -$20.9M | -$20.4M | -$10.6M | -$24.2M | -$15.1M | $7.1M | $12.1M | $13.4M |
| Inversiones (CapEx) | -$1.7M | -$1.4M | -$1.5M | -$753000 | -$142000 | -$409000 | -$334000 | -$148000 | -$163000 | -$292000 |
| Adquisiciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Recompra de Acciones | 0 | 0 | -$404000 | 0 | 0 | 0 | 0 | 0 | 0 | -$251000 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$4.7M | -$11.2M | -$22.4M | -$21.2M | -$10.7M | -$24.6M | -$15.4M | $7.0M | $11.9M | $13.1M |
Flujo de Caja (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Flujo de Caja Operativo | $3.7M | $679000 | -$1.2M | $2.8M |
| Inversiones (CapEx) | -$24000 | -$101000 | -$61000 | -$89000 |
| Flujo de Caja Libre | $3.7M | $578000 | -$1.3M | $2.7M |
| Dividendos Pagados | 0 | 0 | 0 | 0 |
| Compensación en Acciones | $1.8M | $1.7M | $1.7M | $1.7M |
Crecimiento y Márgenes (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Crecimiento Ingresos (anual) | | -2.1% | +48.8% | +46.7% | +28.0% | +13.8% | +6.8% | +16.0% | +19.2% | +29.9% |
| Crecimiento Beneficio Neto (anual) | | -288.6% | -192.8% | +3.5% | +38.0% | -36.2% | +39.0% | +70.1% | +273.1% | +103.3% |
| Crecimiento BPA (anual) | | -231.2% | -134.6% | +8.2% | +41.1% | -21.2% | +40.0% | +70.8% | +257.1% | +100.0% |
| Cambio en Acciones (anual) | | +19.6% | +23.3% | +3.7% | +7.0% | +10.0% | +3.8% | +7.5% | +6.3% | +7.2% |
| Crecimiento FCF (anual) | | -139.3% | -100.4% | +5.2% | +49.3% | -128.7% | +37.2% | +145.2% | +71.4% | +10.0% |
| Margen Bruto | 48.0% | 49.4% | 50.9% | 55.7% | 59.5% | 61.5% | 59.4% | 60.8% | 61.8% | 64.3% |
| Margen Operativo | -13.4% | -77.2% | -105.1% | -67.6% | -33.5% | -40.1% | -25.9% | -6.7% | 7.8% | 11.0% |
| Margen EBITDA | -11.5% | -73.9% | -102.4% | -64.3% | -31.0% | -37.7% | -20.3% | -3.9% | 10.4% | 15.2% |
| Margen Neto | -13.5% | -53.7% | -105.6% | -69.4% | -33.6% | -40.2% | -23.0% | -5.9% | 8.6% | 13.4% |
| Margen FCF | -21.5% | -52.6% | -70.9% | -45.8% | -18.1% | -36.4% | -21.4% | 8.3% | 12.0% | 10.2% |
| Tasa Impositiva Efectiva | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | 3.4% | 4.5% |
Datos por Acción (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| FCF por Acción | $-0.12 | $-0.25 | $-0.41 | $-0.37 | $-0.18 | $-0.37 | $-0.22 | $0.09 | $0.15 | $0.15 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $37.3M | $44.6M | $55.0M | $57.1M | $61.1M | $67.2M | $68.9M | $70.5M | $79.7M | $79.2M |
Qué mirar en Biotech
La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.
- Cash Runway — Meses de caja al ritmo de gasto actual. <18 meses = riesgo de dilución urgente
- Cash burn anual — Ritmo al que queman caja operativa. Comparar con posición de caja para proyectar runway
- Total Debt — Biotech sin ingresos + deuda = receta para bancarrota
- I+D / Capitalización — Cuánto invierten en pipeline vs lo que vale la empresa — indicador de intensidad investigadora
- Market cap / Cash — Si cotiza cerca de su caja, el mercado le da ~0 valor al pipeline — puede ser oportunidad o trampa
Rentabilidad
| Rentabilidad sobre capital | 20.50% |
| Rentabilidad sobre capital invertido | 8.75% |
| Rentabilidad sobre activos | 15.00% |
| Margen bruto | 64.24% |
| Margen operativo | 6.67% |
| Margen neto | 12.39% |
Salud financiera
| Deuda / Patrimonio | 0.03 |
| Ratio corriente | 6.50 |
| Piotroski F-Score | 7 |
| Altman Z-Score | 10.48 |
Ratios Clave (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| P/E | -42.17 | -24.42 | -5.62 | -7.70 | -14.55 | -9.35 | -7.00 | -20.43 | 48.27 | 28.91 |
| P/VC | 12.38 | 5.26 | 6.94 | 12.03 | 17.85 | 7.92 | 4.04 | 3.54 | 9.18 | 6.58 |
| P/V | 5.70 | 13.36 | 5.98 | 5.31 | 4.95 | 3.73 | 1.61 | 1.21 | 4.25 | 3.89 |
| Margen Bruto | 48.0% | 49.4% | 50.9% | 55.7% | 59.5% | 61.5% | 59.4% | 60.8% | 61.8% | 64.3% |
| Margen Operativo | -13.4% | -77.2% | -105.1% | -67.6% | -33.5% | -40.1% | -25.9% | -6.7% | 7.8% | 11.0% |
| Margen Neto | -13.5% | -53.7% | -105.6% | -69.4% | -33.6% | -40.2% | -23.0% | -5.9% | 8.6% | 13.4% |